Spironolactone for resistant hypertension - Hard to resist?

The Lancet

Volumn 386, Issue 10008, 2015, Pages 2032-2034

  Sternlicht, Hillel ^a   Bakris, George L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISOPROLOL; CHLORTALIDONE; DOXAZOSIN; FINERENONE; INDAPAMIDE; SPIRONOLACTONE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; MINERALOCORTICOID ANTAGONIST;

AFRICAN AMERICAN; AFRICAN CARIBBEAN; BLOOD PRESSURE REGULATION; HUMAN; HYPERALDOSTERONISM; HYPERKALEMIA; KIDNEY DENERVATION; NOTE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESISTANT HYPERTENSION; SODIUM INTAKE; SODIUM RETENTION; SYSTOLIC BLOOD PRESSURE; FEMALE; HYPERTENSION; MALE;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; BISOPROLOL; DOXAZOSIN; FEMALE; HUMANS; HYPERTENSION; MALE; MINERALOCORTICOID RECEPTOR ANTAGONISTS; SPIRONOLACTONE;

EID: 84947866664     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)00264-0     Document Type: Note

References (12)

1. DA Calhoun, D Jones, S Textor et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Hypertension 51 2008 1403 1419
2. O Jung, JL Gechter, C Wunder et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis J Hypertens 31 2013 766 774
3. PA Sarafidis, P Georgianos, GL Bakris Resistant hypertension - its identification and epidemiology Nat Rev Nephrol 9 2013 51 58
4. R Iliescu, TE Lohmeier, I Tudorancea, L Laffin, GL Bakris Renal denervation for the treatment of resistant hypertension Am J Physiol Renal Physiol 2015 10.1152/ajprenal.00246.2015 published online July 29.
5. K Dahal, S Kunwar, J Rijal et al. The effects of aldosterone antagonists in patients with resistant hypertension: a meta-analysis of randomized and nonrandomized studies Am J Hypertens 2015 10.1093/ajh/hpv031 published online March 23.
6. GL Bakris, M Siomos, D Richardson for the VAL-K Study Group ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure Kidney Int 58 2000 2084 2092
7. M Azizi, M Sapoval, P Gosse et al. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial Lancet 385 2015 1957 1965
8. FE Fadl Elmula, P Hoffmann, E Fossum et al. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure Hypertension 62 2013 526 532
9. B Williams, TM MacDonald, S Morant for The British Hypertension Society's PATHWAY Studies Group Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial Lancet 2015 published online Sept 21. http://dx.doi.org/10.1016/S0140-6736(15)00257-3
10. BM Egan, JN Basile, SU Rehman et al. Plasma renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial Am J Hypertens 22 2009 792 801
11. GL Bakris, R Agarwal, JC Chan et al. Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial JAMA 314 2015 884 894
12. GL Bakris, B Pitt, MR Weir et al. Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease: the AMETHYST-DN randomized clinical trial JAMA 314 2015 151 161